We were told AI would cure disease in years. That’s a fallacy.
Today, over 90% of clinical drug candidates still fail. It costs more than $2 billion and over a decade to bring a single drug to market. And now the industry faces a brutal paradox, which is the promise of exponential progress stuck inside a system governed by diminishing returns.
This is pharma’s version of Eroom’s Law, i.e. the inverse of Moore’s Law, where the return on drug development declines as science
Read More
Life Sciences | News, Analysis, Insights - HIT Consultant
Causaly Introduces First Agentic AI Platform Built for Life Sciences Research and Development
What You Should Know:
- Causaly today announced Causaly Agentic Research, an agentic AI platform designed specifically for life sciences research and development.
- Built to deliver transparency and scientific rigor, the platform’s specialized AI agents access, analyze, and synthesize internal and external biomedical knowledge and competitive intelligence—so teams can automate complex workflows, uncover novel insights, and move from hypothesis to decision faster and with greater
Read More
Inato Unveils AI Capabilities to Transform Clinical Trial Site Selection
What You Should Know:
- Today, Inato unveiled new AI capabilities to enhance and accelerate site selection. Sponsors can now use Inato’s platform to create and execute data-driven site selection scenarios based on real-time interest and verified data from over 5,500 sites quickly and easily.
- The new capabilities fill an acute gap for sponsor decision-makers, arming them with the insights they need to quickly and confidently choose the right mix of sites for each trial.
Inato Unveils
Read More
LabConnect, OmniScience to Deliver Agentic AI Solution for Real-Time Clinical Trial Lab Insights
What You Should Know:
- LabConnect, a global provider of central laboratory services, has announced a strategic collaboration with OmniScience, the AI company behind the Vivo platform.
- Together, the companies will deliver an AI Agentic solution to give sponsors intelligent, real-time insights from clinical trial lab data.
Transforming Lab Data into Real-Time Action
Clinical trial lab data is often complex, siloed, and delayed, which can lead to slow decision-making
Read More
Verily Sued by Former Executive Over Alleged HIPAA Breaches
What You Should Know:
- Verily, a subsidiary of Alphabet, is facing a lawsuit from a former executive who alleges the company repeatedly covered up HIPAA breaches that affected more than 25,000 patients, CNBC first reports.
- Ryan Sloan, who served as chief commercial officer for Verily's diabetes and hypertension business, claims he was wrongfully fired after reporting his concerns to senior management. The lawsuit, filed in federal court in San Francisco, has not been
Read More
Proscia Launches AI Solution to Advance Precision Medicine
What You Should Know:
- Proscia®, a pathology AI company, has announced the launch of Proscia Aperture™, a new precision medicine solution designed to automatically identify eligible patients for clinical trials at the moment of diagnosis.
- The AI-powered tool aims to tackle one of healthcare’s most significant challenges: connecting patients with life-saving therapies and accelerating the development of new treatments.
Transforming Pathology Data Into Real-Time
Read More
Evolv Launches GLP-1 Supplement, a Natural Alternative to Weight-Loss Drugs
What You Should Know:
- Pioneering biomimetics company Evolv introduces its first product Evolv GLP-1: the first ingestible, natural GLP-1 peptide designed for effective and accessible weight management
- The oral GLP-1 supplement was created using a proprietary yeast strain engineered to produce a new molecule that delivers the full power of GLP-1 naturally. Unlike synthetic drugs, this non-habituating supplement is designed to help individuals manage appetite and metabolism without
Read More
Living Optics and NVIDIA Jetson Showcase Real-Time Hyperspectral Imaging
What You Should Know:
- Living Optics, a leader in hyperspectral imaging (HSI), has announced its latest real-time blood perfusion demonstration, which was built on the NVIDIA Jetson platform. The demonstration offers a glimpse into the future of edge AI for healthcare, life sciences, and precision imaging.
- The live demo showcases how the company’s spectral vision technology can distinguish between oxygenated and deoxygenated blood in real-time. This capability provides critical
Read More
Revalia Bio Launches ‘Human Data Trials’ with $14.5M to Transform Drug Development
What You Should Know:
- Revalia Bio Inc., a new pre-clinical research company secures $14.5M in seed funding round to support the launch of its "Human Data Trials".
- The funding was co-led by America's Frontier Fund and Sierra Ventures, with participation from Roger Ferguson, former Vice Chair of the U.S. Federal Reserve, and other existing investors. This brings Revalia's total funding to $19.5M.
A New Paradigm for Pre-Clinical Research
The investment comes at a crucial time
Read More
Ketryx Raises $39M to Accelerate AI-Powered Compliance in Life Sciences
What You Should Know:
- Ketryx, the AI-powered compliance platform helping life sciences companies ship safer products faster, today announced a $39 million Series B led by Transformation Capital, with participation from existing investors including Lightspeed Venture Partners, MIT’s E14 Fund, Ubiquity Ventures, and 53 Stations.
- This latest round brings the company’s total funding to over $55 million, and Vinay Shah, Partner and Founding Team Member at Transformation
Read More
